Mylan Laboratories launches share buyback

June 15, 2005 at 6:12 PM

CANONSBURG, Pa., June 15 (UPI) -- Mylan Laboratories Inc., a Pennsylvania-based generic drugmaker, plans to buy back nearly a quarter of its shares and double its dividend.

The moves come as takeover artist Carl Icahn, Mylan's biggest shareholder, has been trying to replace the company's board and boost his own stake in the company, the Pittsburgh Post-Gazette reported.

"We are pleased that Mylan has finally announced actions attempting to enhance shareholder value," Icahn said Wednesday.

"However, it is a sad commentary that Mylan needed the strong prodding of its largest shareholder to take the actions that were announced this morning. Additionally, it should be noted that Mylan's partial tender offer is for the most part at a price below our acquisition proposal."

Icahn has been offering $20 per share for Mylan, while the company is paying about $20.50 for its own shares, the newspaper said.

Like Us on Facebook for more stories from UPI.com  
Topics: Carl Icahn
Latest Headlines
Top Stories
B-52 bombers demo long reach of U.S. air power
Army orders tactical trucks from Oshkosh
Reddit CEO Ellen Pao offers to improve communication in wake of firing scandal
Raytheon wins IDIQ contract for Army sensor systems
Oil markets hammered by Greece, Iran and China